Questionnaire for Depression in Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to create a new tool to measure depression in older adults dealing with cancer. It focuses on understanding how cancer treatment and aging affect mood and seeks to improve diagnosis and treatment options. Participants will contribute by answering questions and participating in interviews to refine the tool. Individuals diagnosed with cancer who have experienced depression-related symptoms, such as feeling down or anxious, might be a good fit. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance mental health care for older adults with cancer.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to create a specialized tool to better identify depression in older cancer patients. While current methods might not fully capture the unique experiences of this group, this new questionnaire is designed specifically for them, which could lead to more accurate diagnoses. By focusing on themes directly from patient interviews, this tool has the potential to uncover insights that other general depression assessments might miss, paving the way for more tailored and effective care.
Who Is on the Research Team?
Christian Nelson, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase 1
Approximately 15 depressed and 15 non-depressed patients undergo individual interviews
Phase 2
Development of questionnaire based on themes from Phase 1
Phase 3
Newly developed questionnaire is given to approximately 150 cancer patients
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- newly developed questionnaire
- Patient Interviews
- Pilot Testing the Draft Measure
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
This protocol aims to design, develop and pilot test a psychometric assessment for depression in older cancer patients. The study is divided in three phases. In Phase 1, approximately 15 depressed patients (as determined clinically) and approximately 15 non-depressed patients will undergo individual interviews. In Phase 2, the team will use the themes and subthemes obtained in Phase 1 to write a set of indicators into questionnaire form. In Phase 3, the newly developed questionnaire will be given to a sample of approximately 150 cancer patients who meet the eligibility criteria. Survey results obtained from this sample of 150 patients will be used to assess internal consistency, conduct item analysis, and determine the unique content of the proposed instrument.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Fordham University
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.